ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
63 546,39
1,04%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Aadi Bioscience Inc (AADI)

  7. Aadi Bioscience Inc (AADI) Actualités

AADI Aadi Bioscience Inc

2,0801
0,0601 (2,98%)
04 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Aadi Bioscience Inc AADI NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,0601 2,98% 2,0801 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
2,06 2,02 2,13 2,12 2,02
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
01/5/202414:01PRNUSAadi Bioscience to Report First Quarter 2024 Results and..
09/4/202414:00PRNUSAadi Bioscience to Present New Non-clinical Data..
17/3/202413:00PRNUSAadi Bioscience Presents New Subgroup Analysis of Patients..
13/3/202413:00PRNUSAadi Bioscience Announces Financial Results for the Fourth..
06/3/202414:00PRNUSAadi Bioscience to Report Fourth Quarter and Full-Year 2023..
05/3/202422:30PRNUSAadi Bioscience to Present Multiple Posters at the American..
05/3/202401:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202401:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202401:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202422:08PRNUSAadi Bioscience Announces Publication of Long-Term Efficacy..
01/3/202419:07EDGAR2Form 144 - Report of proposed sale of securities
26/2/202422:05PRNUSAadi Bioscience to Present at the TD Cowen 44th Annual..
12/2/202423:21EDGAR2Form S-8 - Securities to be offered to employees in employee..
12/2/202423:16EDGAR2Form S-3 - Registration statement under Securities Act of..
02/2/202423:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202422:05PRNUSAadi Bioscience Announces Poster Presentations at the 2024..
19/1/202422:05PRNUSAadi Bioscience Announces Poster Presentations at the 2024..
03/1/202401:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202323:08EDGAR2Form 8-K - Current report
14/12/202322:05PRNUSAadi Bioscience Reports Interim Results from PRECISION1..
07/12/202322:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202300:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202317:37EDGAR2Form 144 - Report of proposed sale of securities
08/11/202322:54EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202322:28EDGAR2Form 8-K/A - Current report: [Amend]
08/11/202314:07EDGAR2Form 8-K - Current report
08/11/202314:00PRNUSAadi Bioscience Reports Financial Results for the Third..
06/11/202322:05PRNUSAadi Bioscience to Participate in Jefferies London..
02/11/202323:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202321:05PRNUSAadi Bioscience to Report Third Quarter 2023 Results and..
19/10/202322:05PRNUSAadi Bioscience Announces Poster Presentations on..
12/10/202322:05PRNUSAadi Bioscience Announces Poster Presentations at 2023..
05/10/202322:05PRNUSAadi Bioscience Announces Poster Presentations at the North..
04/10/202300:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202300:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202300:47EDGAR2Form 3 - Initial statement of beneficial ownership of..
03/10/202322:05PRNUSAadi Bioscience Grants New CEO Dave Lennon, Ph.D. Inducement..
02/10/202314:30EDGAR2Form 8-K - Current report
02/10/202314:00PRNUSAadi Bioscience Appoints Dave Lennon, Ph.D. as President and..
20/9/202322:30PRNUSAadi Bioscience Announces Poster Presentations at 2023..
07/9/202301:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202314:00PRNUSAadi Bioscience to Participate at Upcoming Investor..
01/9/202317:33EDGAR2Form 144 - Report of proposed sale of securities
09/8/202322:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202314:05EDGAR2Form 8-K - Current report
09/8/202314:00PRNUSAadi Bioscience Announces Financial Results for the Second..
03/8/202322:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/8/202314:00PRNUSAadi Bioscience to Report Second Quarter 2023 Results and..
07/7/202301:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/7/202317:48EDGAR2Form 144 - Report of proposed sale of securities

Dernières Valeurs Consultées

NASDAQ
AADI
Aadi Bioscience
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés